Table I.
Baseline characteristics for all patients with TAAA
| Non-operative | Open | Endovascular | Hybrid | Partial | Total | P | |
|---|---|---|---|---|---|---|---|
| N | 205 | 54 | 68 | 24 | 81 | 432 | |
| Age, median, IQR | 73.6 (67.2, 79.9) | 62.0 (41.5, 69.1) | 74.9 (68.2, 78.5) | 63.8 (55.2, 74.2) | 71.1 (61.6, 77.3) | 72.0 (63.8, 78.6) | <0.001 |
| Sex | <0.001 | ||||||
| Male | 49.8% | 66.7% | 75.0% | 62.5% | 69.1% | 60.2% | |
| Female | 50.2% | 33.3% | 25.0% | 37.5% | 30.9% | 39.8% | |
| Diameter, mean (cm) | 6.3 (1.3) | 6.8 (1.6) | 6.7 (1.2) | 6.8 (0.9) | 6.4 (1.1) | 6.5 (1.3) | 0.018 |
| Presentation | 0.18 | ||||||
| Asymptomatic | 77.6% | 70.4% | 82.4% | 79.2% | 64.2% | 74.9% | |
| Symptomatic | 15.8% | 25.9% | 17.6% | 16.7% | 23.5% | 18.2% | |
| Ruptured | 6.6% | 3.7% | 0.0% | 4.2% | 12.3% | 6.1% | |
| Dissection | 25.0% | 37.0% | 4.4% | 34.8% | 51.9% | 28.8% | <0.001 |
| Crawford classification | <0.001 | ||||||
| Extent I | 13.0% | 7.4% | 14.7% | 8.3% | 37.0% | 16.9% | |
| Extent II | 40.0% | 33.3% | 22.1% | 66.7% | 50.6% | 39.8% | |
| Extent III | 11.0% | 14.8% | 19.1% | 4.2% | 7.4% | 11.7% | |
| Extent IV | 33.5% | 40.7% | 42.6% | 16.7% | 3.7% | 29.3% | |
| Extent V | 2.5% | 3.7% | 1.5% | 4.2% | 1.2% | 2.3% | |
| CTD | 2.0% | 22.2% | 0.0% | 25.0% | 4.9% | 6.0% | <0.001 |
| Previous aortic surgery | 44.9% | 38.9% | 44.1% | 45.8% | 40.7% | 43.3% | 0.92 |
| Significant comorbidity | 50.5% | 7.5% | 17.7% | 13.0% | 23.1% | 32.7% | <0.001 |
CTD, connective tissue disorder